Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,391
Total Claims
$865K
Drug Cost
520
Beneficiaries
$1,663
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 16,767 Hospitalist providers
-70%
Opioid rate vs peers
0.9% vs 3.0% avg
+289%
Cost per patient vs peers
$1,663 vs $427 avg
+206%
Brand preference vs peers
16.0% vs 5.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.9%
Opioid Rate
111
Opioid Claims
$3,971
Opioid Cost
11.7%
Long-Acting Rate
Brand vs Generic
Brand: 1,978 claims · $608K
Generic: 10,357 claims · $252K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 275 | $76K |
| Pimavanserin Tartrate | 33 | $74K |
| Rivaroxaban | 168 | $46K |
| Emtricitabine/Tenofov Alafenam | 11 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 61 | $23K |
| Raltegravir Potassium | 12 | $21K |
| Dolutegravir Sodium | 18 | $21K |
| Rifaximin | 14 | $17K |
| Empagliflozin | 56 | $17K |
| Eslicarbazepine Acetate | 26 | $15K |
| Mirabegron | 68 | $15K |
| Ipratropium/Albuterol Sulfate | 28 | $14K |
| Dulaglutide | 16 | $13K |
| Insulin Aspart | 43 | $13K |
| Dextromethorphan Hbr/Quinidine | 17 | $13K |
Prescribing Profile
Patient Profile
77
Avg Age
59%
Female
2.20
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About